CN101774958A - N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法 - Google Patents
N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法 Download PDFInfo
- Publication number
- CN101774958A CN101774958A CN200910003043A CN200910003043A CN101774958A CN 101774958 A CN101774958 A CN 101774958A CN 200910003043 A CN200910003043 A CN 200910003043A CN 200910003043 A CN200910003043 A CN 200910003043A CN 101774958 A CN101774958 A CN 101774958A
- Authority
- CN
- China
- Prior art keywords
- crystallization
- propyl
- ketone
- pyrrolin
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
Description
Claims (10)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100030434A CN101774958B (zh) | 2009-01-13 | 2009-01-13 | N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法 |
PCT/CN2009/074688 WO2010081341A1 (zh) | 2009-01-13 | 2009-10-29 | N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法 |
HK10111666.8A HK1145674A1 (zh) | 2009-01-13 | 2010-12-15 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100030434A CN101774958B (zh) | 2009-01-13 | 2009-01-13 | N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101774958A true CN101774958A (zh) | 2010-07-14 |
CN101774958B CN101774958B (zh) | 2012-01-11 |
Family
ID=42339421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100030434A Active CN101774958B (zh) | 2009-01-13 | 2009-01-13 | N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法 |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101774958B (zh) |
HK (1) | HK1145674A1 (zh) |
WO (1) | WO2010081341A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104193664A (zh) * | 2014-08-22 | 2014-12-10 | 山东铂源药业有限公司 | 一种艾瑞昔布的合成方法 |
CN108778280A (zh) * | 2016-11-07 | 2018-11-09 | 江苏恒瑞医药股份有限公司 | 一种GnRH受体拮抗剂的多晶型及其制备方法 |
CN109553564A (zh) * | 2017-09-25 | 2019-04-02 | 江苏恒瑞医药股份有限公司 | 一种艾瑞昔布的纯化方法 |
CN109553563A (zh) * | 2017-09-25 | 2019-04-02 | 江苏恒瑞医药股份有限公司 | 一种吡咯类化合物及其制备方法、用途 |
CN109678775A (zh) * | 2017-10-18 | 2019-04-26 | 江苏恒瑞医药股份有限公司 | 一种cox-2选择性抑制剂的晶型及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1134413C (zh) * | 2000-04-17 | 2004-01-14 | 中国医学科学院药物研究所 | 含有磺酰基吡咯烷酮化合物及其制法和药物用途 |
US7112605B2 (en) * | 2002-08-08 | 2006-09-26 | Research Institute of Materia Medica Chinese Acadamy of Medical Sciences | Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof |
-
2009
- 2009-01-13 CN CN2009100030434A patent/CN101774958B/zh active Active
- 2009-10-29 WO PCT/CN2009/074688 patent/WO2010081341A1/zh active Application Filing
-
2010
- 2010-12-15 HK HK10111666.8A patent/HK1145674A1/xx unknown
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104193664A (zh) * | 2014-08-22 | 2014-12-10 | 山东铂源药业有限公司 | 一种艾瑞昔布的合成方法 |
CN104193664B (zh) * | 2014-08-22 | 2016-08-24 | 山东铂源药业有限公司 | 一种艾瑞昔布的合成方法 |
CN108778280A (zh) * | 2016-11-07 | 2018-11-09 | 江苏恒瑞医药股份有限公司 | 一种GnRH受体拮抗剂的多晶型及其制备方法 |
CN109553564A (zh) * | 2017-09-25 | 2019-04-02 | 江苏恒瑞医药股份有限公司 | 一种艾瑞昔布的纯化方法 |
CN109553563A (zh) * | 2017-09-25 | 2019-04-02 | 江苏恒瑞医药股份有限公司 | 一种吡咯类化合物及其制备方法、用途 |
CN109678775A (zh) * | 2017-10-18 | 2019-04-26 | 江苏恒瑞医药股份有限公司 | 一种cox-2选择性抑制剂的晶型及其制备方法 |
CN109678775B (zh) * | 2017-10-18 | 2020-12-04 | 江苏恒瑞医药股份有限公司 | 一种cox-2选择性抑制剂的晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
HK1145674A1 (zh) | 2011-04-29 |
CN101774958B (zh) | 2012-01-11 |
WO2010081341A1 (zh) | 2010-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2876884C (en) | Crystalline form i of tyrosine kinase inhibitor dimaleate and preparation methods thereof | |
CN101774958B (zh) | N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法 | |
AU2014224456B2 (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
US9856270B2 (en) | Dolutegravir salts | |
EP3275866B1 (en) | P-toluenesulfonate for mek kinase inhibitor, and crystal form thereof and preparation method therefor | |
JP5680161B1 (ja) | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 | |
JP2005097120A (ja) | 4−ヒドロキシピペリジン誘導体の非潮解性塩 | |
JP2018503608A (ja) | 塩酸ヨンケナフィルの多形体及びその調製方法、組成物並びに用途 | |
CN107001284B (zh) | 一种雄性激素受体抑制剂的结晶形式及其制备方法 | |
JP5888612B2 (ja) | 縮合ピリジン化合物塩の結晶 | |
CN103382179A (zh) | 英加韦林的多晶型物及其制备方法 | |
WO2018209809A1 (zh) | 一种5型磷酸二酯酶抑制剂的甲磺酸盐多晶物及其制备方法和应用 | |
JP5795693B2 (ja) | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 | |
CN106478616B (zh) | 一种gpr40激动剂的结晶形式及其制备方法 | |
CN112703190B (zh) | Hdac6选择性抑制剂的晶型及其应用 | |
CN106518773A (zh) | 一种雄性激素受体抑制剂的结晶形式及其制备方法 | |
KR100906288B1 (ko) | 결정질 acat 억제제 | |
CN101775005B (zh) | 盐酸卡屈沙星i型结晶及其制备方法 | |
TWI468391B (zh) | N-正丙基-3-(4-甲基苯基)-4-(4-甲磺醯基苯基)-2,5-二氫吡咯-2-酮的i型結晶及其製造方法 | |
RU2575923C2 (ru) | Органические соли бромфенака и способ их получения, содержащая их композиция и их применение | |
WO2016101912A1 (zh) | 一种表皮生长因子受体激酶抑制剂的盐的晶型及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1145674 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1145674 Country of ref document: HK |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160829 Address after: 222002 No. 145, Renmin East Road, Sinpo District, Jiangsu, Lianyungang Patentee after: Hengrui Medicine Co., Ltd., Jiangsu Prov. Patentee after: Jiangsu Sheng Di Pharmaceutical Co., Ltd. Address before: 222002 No. 145, Renmin East Road, Sinpo District, Jiangsu, Lianyungang Patentee before: Hengrui Medicine Co., Ltd., Jiangsu Prov. |